Clinical Trials Directory

Trials / Completed

CompletedNCT01586312

Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells

Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells (MSV*) *MSV: Mesenchymal Stromal Cells From Valladolid

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Red de Terapia Celular · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

In this study we want to evaluate the clinical use of allogenic mesenchymal stem cells (MSC), obtained from bone marrow of healthy donors, for treatment of knee osteoarthritis. The trial is based in our own previous results with autologous MSC (ongoing NCT01183728 trial). We propose here a multicenter, phase I-II clinical trial, prospective, randomized, blinded, and controlled for the treatment of osteoarthritis (degrees II and III and IV). The assay consists of two arms with 15 patients each one. Patients in the experimental arm will be given an intra-articular transplantation of allogenic MSC, expanded "Ex Vivo" with our GMP-compliant procedure (MSV, PEI No. 10-134, authorized by the Competent Authority; same as in NCT01183728). In the control arm a standard treatment with intra-articular injection of hyaluronic acid shall be given. We shall follow the evolution of pain, disability, quality of life and quantitative changes in structure and composition of cartilage determined by T2-weighted MRI relaxation (Cartigram) for one year.

Conditions

Interventions

TypeNameDescription
OTHERAllogenic mesenchymal stromal cells injectionMesenchymal stem cells prepared from bone marrow of healthy donors and expanded for 3-4 weeks according to our procedure described in PEI Num. 10-134, authorized by the Spanish Medicine Agency
DRUGHyaluronic AcidIntra-articular injection of 60 mg of hyaluronic acid (Durolane) in a single injection (3 ml)

Timeline

Start date
2012-04-01
Primary completion
2013-12-01
Completion
2014-06-01
First posted
2012-04-26
Last updated
2015-10-16
Results posted
2014-11-06

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT01586312. Inclusion in this directory is not an endorsement.